相关实验视频
Updated: Jun 15, 2025

07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
24.6K
在心力衰竭患者与保存的喷射分数和自身免疫性疾病患者的氧化启动后住院治疗
Munaza Riaz1, Haesuk Park1, Carl J Pepine2
1Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida, USA.
Journal of internal medicine
|August 28, 2024
概括
氧化 (HCQ) 的使用与HFpEF和自身免疫性疾病患者心力衰竭住院治疗的减少有关. 这项研究表明,HCQ可能会减少这一高风险组的心血管事件.
科学领域:
- 心脏病学 心脏病学
- 类风湿病学 类风湿病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 已知氧化 (HCQ) 可以减少自身免疫患者的心血管事件.
- 有关HCQ的心血管安全存在担忧,促使进一步调查.
- 保存喷射分数 (HFpEF) 的心力衰竭代表了相当大的心血管疾病负担.
研究的目的:
- 评估启动氧化chloroquine (HCQ) 和住院治疗心力衰竭和所有原因之间的联系.
- 评估HCQ对被诊断患有HFpEF和自身免疫疾病的患者的影响.
主要方法:
- 一项队列研究利用了MarketScan数据库 (2007-2019) 包括患有HFpEF和自身免疫性疾病的患者.
- 倾向性得分匹配用于比较HCQ用户与非用户 (1:≥3比率).
- 考克斯的比例危险回归模型分析了与HF相关的和所有原因的住院治疗.
主要成果:
- 这项研究包括2229名患者 (592名HCQ使用者,1637名非使用者) 的后倾向分数匹配.
- HCQ使用者表现出与心力衰竭相关的住院住院风险明显降低 (aHR,0.44;95% CI,0.24-0.82).
- 在HCQ使用者中观察到所有原因住院的风险降低 (aHR,0.69;95%CI,0.57-0.83).
结论:
- 开始使用氧化 (HCQ) 与患有HFpEF和自身免疫性疾病的患者中HF相关住院病例的减少有关.
- 开始HCQ也与该患者队伍内全因住院病例的减少相关.
- 研究结果表明,HCQ在特定患者群体中具有潜在的心脏保护作用.
更多相关视频
相关概念视频
Heart Failure Drugs: Diuretics
352
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
352
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
405
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
405
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Imaging Studies for Cardiovascular System I:Echocardiography
303
Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
303
Heart Failure Drugs: Inotropic Agents
545
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
545
Exercise and Cardiovascular Response
751
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
751

